PRESS RELEASE published on 09/02/2025 at 11:04, 8 months 21 days ago Annual Meeting 2025 - DF Group faces new political challenges DF Deutsche Forfait AG holds its Annual Meeting in 2025, facing new political challenges. Despite profit achievement, dividend proposal rejected. Strategic realignment in foreign trade financing for future growth Annual Meeting Strategic Realignment DF Deutsche Forfait AG Profits Foreign Trade Financing
BRIEF published on 04/30/2025 at 16:29, 1 year ago DF Deutsche Forfait AG annonce de solides performances financières pour 2024 Rapport Annuel DF Deutsche Forfait AG Résultats Financiers 2024 Augmentation Du Bénéfice Brut Expansion Des Fusions Et Acquisitions
BRIEF published on 04/30/2025 at 16:29, 1 year ago DF Deutsche Forfait AG Reports Strong 2024 Financial Performance Annual Report DF Deutsche Forfait AG 2024 Financial Performance Gross Profit Increase M&A Expansion
PRESS RELEASE published on 04/30/2025 at 16:24, 1 year ago Another successful year ended - Annual Report 2024 published DF Deutsche Forfait AG published its Annual Report 2024, reporting a successful financial year with increased business volume and gross profit. Earnings before taxes expected to rise in 2025 Financial Year Dividend Earnings Before Taxes DF Deutsche Forfait AG Annual Report 2024
BRIEF published on 04/30/2025 at 10:11, 1 year ago Le groupe DF se lance sur le marché lucratif du plasma sanguin DF Deutsche Forfait AG Stratégie De Fusions Et Acquisitions Collecte De Plasma Secteur Pharmaceutique Marché Du Plasma Sanguin
BRIEF published on 04/30/2025 at 10:11, 1 year ago DF Group Ventures into Lucrative Blood Plasma Market M&A Strategy DF Deutsche Forfait AG Pharmaceutical Sector Plasma Collection Blood Plasma Market
PRESS RELEASE published on 04/30/2025 at 10:06, 1 year ago DF Group enters blood plasma market DF Group acquires Ruhr-Plasma-Zentrum Bochum GmbH assets to enter blood plasma market, expanding into lucrative pharmaceutical sector with estimated $50 billion market volume M&A Strategy Pharmaceutical Sector DF Group Blood Plasma Market Ruhr-Plasma-Zentrum
BRIEF published on 04/03/2025 at 13:36, 1 year 1 month ago Change in DF Deutsche Forfait AG's Shareholder Structure Shareholder Structure DF Deutsche Forfait Trade Finance Solutions Dr Heinrich Schulz Dr Shahab Manzouri
BRIEF published on 04/03/2025 at 13:36, 1 year 1 month ago Modification de la structure actionnariale de DF Deutsche Forfait AG Structure De L'actionnariat DF Deutsche Forfait Dr Heinrich Schulz Dr Shahab Manzouri Solutions De Financement Du Commerce
PRESS RELEASE published on 04/03/2025 at 13:31, 1 year 1 month ago EQS-Adhoc: Change in the shareholder structure DF Deutsche Forfait AG announces change in shareholder structure with Trade Finance Solutions acquiring 16.05% shares while Dr Shahab Manzouri decreases share ownership to 63.32% Shareholder Structure DF Deutsche Forfait AG Trade Finance Solutions Dr Heinrich Schulz Dr Shahab Manzouri
Published on 05/23/2026 at 19:45, 6 hours 21 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 22 hours 51 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 23 hours 6 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 23 hours 41 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 23 hours 41 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 16:30, 9 hours 36 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 10 hours 9 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 4 hours ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 1 day 4 hours ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 1 day 6 hours ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 19:35, 1 day 6 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 8 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 8 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 13 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 13 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
